AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.92M invested in AIM ImmunoTech in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$14.7K
2
+$12K
3
+$12K

Top Sellers

1
-$15.5K
2
-$6.99K
3
-$6K
4
TSS
Two Sigma Securities
New York
-$3K
5
Goldman Sachs
Goldman Sachs
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$766K
2
$720K
3
$246K
4
$31K
5
$27K
6
$25K
7
$22K
8
$14K
9
$12K
10
$12K
11
$11K
12
$9K
13
$9K
14
$7K
15
$3K
16
$3K
17
$2K
18
$1.33K
19
$1K
20
$1K
21
$1K
22
$119
23
–
24
–
25
–